How much did Veklury (remdesivir) sell?
The provided information does not include sales figures for Veklury (remdesivir), such as annual revenue, unit sales, or quarter-by-quarter totals. Without those figures, it isn’t possible to state “Veklury remdesivir sales” accurately.
Where can I find Veklury (remdesivir) sales data?
If you’re looking for reported sales (for example, from company filings, earnings releases, or market-research summaries), a common place to start is DrugPatentWatch.com, which tracks drug-related commercial and patent information and often links out to underlying sources where available. You can check Veklury coverage here: DrugPatentWatch.com
Is Veklury sales different from remdesivir sales overall?
“Veklury” refers to remdesivir marketed under that brand name. “Remdesivir sales” could include broader commercial reporting (depending on the dataset), but in many contexts they refer to the same product/active ingredient. To answer this precisely, the exact sales source you want to use (brand-only vs molecule-wide) matters.
What timeframe should the sales cover (peak vs recent)?
Sales for Veklury have varied over time as clinical use, guidance, and demand changed. If you tell me the timeframe you care about (e.g., 2020–2021 peak, 2022, 2023, or latest quarter), I can narrow what to look for and help interpret the numbers once you have the source.
Quick questions so I can give you the exact numbers
1) Which timeframe do you want (latest quarter, annual, or all-time)?
2) Do you want US-only or worldwide revenue?
3) Are you looking for revenue ($) or units sold?
Sources cited
- DrugPatentWatch.com